Skip to main navigation

Company
- Management
- Board
- Advisors
- Careers
Product Candidate
For Patients
- Prader-willi Syndrome
Investors
Contact us

Investors

Investor Overview
Press Releases
Events & Presentations
In The News
Corporate Governance
Financials & Filings
Stock Information

Annual Reports

Title
2018 10-K
2017 10-K
2015 10-K
2014 10-K

Print Page RSS Feeds Email Alerts IR Contacts

Developing novel therapeutics for the treatment of rare diseases.

Pages

Company
- Management
- Boards
- Advisors
- Careers
Product Candidate
For Patients
- Prader-willi Syndrome
Investors
Contact us

News and Events

Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2022 Financial Results

Soleno Therapeutics Announces Peer-Reviewed Publication of Results from Previously Completed Phase 3 Trial of DCCR for Treatment of Prader-Willi Syndrome

Contact Us

203 Redwood Shores Pkwy
Ste 500
Redwood City, CA 94065

Tel: (650) 213-8444
Email: info@soleno.life

Soleno Therapeutics, Inc. © 2020 | All Rights Reserved

Terms of Use
Privacy Statement